Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
Trump says deal reached to disarm Hamas, Israeli support for plan remains uncertain
Kuwait intercepts hostile drones after attacks on vital, military sites
India approves 3.16 trillion rupees for farmer cash scheme through 2031
4 bodies located after 10 climbers go missing on Pakistani mountain
